INSMED INC (INSM)

US4576693075 - Common Stock

29.215  -0.3 (-1%)

Fundamental Rating

2

INSM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 599 industry peers in the Biotechnology industry. Both the profitability and financial health of INSM have multiple concerns. INSM is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

INSM had negative earnings in the past year.
In the past year INSM has reported a negative cash flow from operations.
INSM had negative earnings in each of the past 5 years.
In the past 5 years INSM always reported negative operating cash flow.

1.2 Ratios

INSM's Return On Assets of -54.62% is in line compared to the rest of the industry. INSM outperforms 43.24% of its industry peers.
Industry RankSector Rank
ROA -54.62%
ROE N/A
ROIC N/A
ROA(3y)-33.65%
ROA(5y)-37.77%
ROE(3y)-253.22%
ROE(5y)-202.5%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 78.57%, INSM belongs to the top of the industry, outperforming 86.32% of the companies in the same industry.
In the last couple of years the Gross Margin of INSM has declined.
INSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

INSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INSM has been increased compared to 1 year ago.
Compared to 5 years ago, INSM has more shares outstanding
INSM has a worse debt/assets ratio than last year.

2.2 Solvency

INSM has an Altman-Z score of -2.68. This is a bad value and indicates that INSM is not financially healthy and even has some risk of bankruptcy.
INSM has a Altman-Z score (-2.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.68
ROIC/WACCN/A
WACC10.15%

2.3 Liquidity

A Current Ratio of 4.71 indicates that INSM has no problem at all paying its short term obligations.
INSM has a Current ratio (4.71) which is in line with its industry peers.
A Quick Ratio of 4.31 indicates that INSM has no problem at all paying its short term obligations.
INSM has a Quick ratio of 4.31. This is comparable to the rest of the industry: INSM outperforms 47.13% of its industry peers.
Industry RankSector Rank
Current Ratio 4.71
Quick Ratio 4.31

6

3. Growth

3.1 Past

The earnings per share for INSM have decreased strongly by -44.78% in the last year.
The Revenue has grown by 15.95% in the past year. This is quite good.
The Revenue has been growing by 21.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-44.78%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1.83%
Revenue 1Y (TTM)15.95%
Revenue growth 3Y21.59%
Revenue growth 5YN/A
Revenue growth Q2Q16.74%

3.2 Future

Based on estimates for the next years, INSM will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.78% on average per year.
Based on estimates for the next years, INSM will show a very strong growth in Revenue. The Revenue will grow by 37.61% on average per year.
EPS Next Y-36.15%
EPS Next 2Y-8.39%
EPS Next 3Y3.25%
EPS Next 5Y13.78%
Revenue Next Year22.76%
Revenue Next 2Y20.52%
Revenue Next 3Y28.66%
Revenue Next 5Y37.61%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INSM. In the last year negative earnings were reported.
Also next year INSM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.39%
EPS Next 3Y3.25%

0

5. Dividend

5.1 Amount

No dividends for INSM!.
Industry RankSector Rank
Dividend Yield N/A

INSMED INC

NASDAQ:INSM (2/20/2024, 10:16:07 AM)

29.215

-0.3 (-1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.18B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.62%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 78.57%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.71
Quick Ratio 4.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-44.78%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-36.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.95%
Revenue growth 3Y21.59%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y